-
ASCO GI | Dr. Pashtoon M. Kasi: ctDNA Proven to Guide Adjuvant Chemotherapy in Colorectal Cancer
Despite ctDNA’s nascent role in treatment decision-making, it is a proven marker of MRD in CRC patients, and research increasingly explores its role in guiding treatment across gastrointestinal cancers. At the 2024 ASCO Gastrointestinal Cancers Symposium, Dr. Pashtoon M. Kasi from Weill Cornell Medicine and Dr. Jeanne Tie from the Peter MacCallum Cancer Centre presented…
-
ASCO 2024 | Dr. John Sweetenham: Application of AI Patient Navigation Tool in Colorectal Cancer Screening
At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Alyson B. Moadel from the Albert Einstein Montefiore Medical Center unveiled a study on artificial intelligence (AI). The findings demonstrated that an AI-based patient navigation tool effectively assisted patients who missed initial colonoscopy appointments, significantly increasing screening completion rates. Recently, Dr. John Sweetenham…
-
ASCO 2024 | Dr. Shaalan Beg: Breakthrough Study on Thermal Ablation for Small Colorectal Liver Metastases
At the 2024 ASCO Annual Meeting, a groundbreaking study led by Dr. Martijn Ruben Meijerink from Amsterdam University Medical Center focused on thermal ablation versus surgery for small colorectal liver metastases. This study has the potential to change clinical practice. Dr. Shaalan Beg from the Simmons Comprehensive Cancer Center at the University of Texas Southwestern…
-
Dr. Norbert Claude Gorin: Autologous Transplant Combined with Immunotherapy, Expected to Optimize the Treatment Landscape of AML
Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, “Hematology Frontier” specially invited Dr. Norbert Claude Gorin from Hôpital Saint-Antoine in Paris, a member of the French National…
-
Dr. Salomon Manier: Navigating the Medical Seas, Innovating and Upgrading Treatment Plans for TIE-NDMM Patients
Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, “Hematology Frontier” specially invited Dr. Salomon Manier from the Hematology Department of Lille University Hospital in France to discuss…
-
ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress
Q1: Could you introduce some of the key topics or highlights of this ILCA conference? Dr. Tim Meyer: The International Liver Cancer Association (ILCA) is a prominent multidisciplinary association that…
-
CSCO 2024 | Dr. Lei Tang: Advancements in Modern Imaging Support Immunotherapy Evaluation for Gastric Cancer
The 27th Annual Conference of the Chinese Society of Clinical Oncology (CSCO) took place in Xiamen from September 25–29, 2024. This year’s theme, “Patient-Centered, Sharing the Future,” brought together groundbreaking research and developments. Dr. Lei Tang from Peking University Cancer Hospital delivered an insightful presentation on the current state and challenges of imaging in evaluating…
-
ASCO GI 2024 | Dr. Zhi Peng Discusses Immunotherapy and Targeted Chemotherapy for Gastric Cancer
The 2024 ASCO Gastrointestinal Cancers Symposium (ASCO GI 2024) took place in San Francisco from January 18-20, gathering top experts from around the world to share the latest advances in gastrointestinal cancer research. Dr. Zhi Peng from Peking University Cancer Hospital presented two studies (Abstracts 312 and 317) in the poster session, showcasing the contributions…
Connecting Medical Expertise through Media